FDA has just approved Ed Lilly's tirzepatide for weight loss.
The new drug will be called Zepbound.
Not good news for RMD at first glance, but the pricing, the
fact that insurance companies are starting to exclude weight
loss drugs from their policies and the growing list of side effects
(overweight rats developed thyroid cancer!) should deter a few.
RMD - ASX Charts, page-4
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$34.66 |
Change
-0.100(0.29%) |
Mkt cap ! $21.25B | |||
| Open | High | Low | Value | Volume |
| $34.65 | $34.82 | $34.53 | $45.12M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $34.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $34.76 | 632 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| RMD (ASX) Chart |